RECRUITING

Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence of headaches in the subsequent few days.

Official Title

Does Nerve Block Plus Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hours Better Than Nerve Block Alone?

Quick Facts

Study Start:2023-09-15
Study Completion:2024-09-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06016465

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Meet ICHD-3 Migraine Headache Criteria
  2. * Had a minimum 5-point reduction in headache intensity after nerve block(s) or post- block pain score of 0 to 2
  3. * Nerve block performed with bupivacaine 0.5%
  1. * Head trauma
  2. * Suspicion of secondary headache (i.e. stroke, known tumor, glaucoma)
  3. * Headache in the setting of viral syndrome
  4. * Chronically on steroids
  5. * Known allergy to dexamethasone
  6. * Unable to reach the patient by phone or text for follow-up
  7. * Gestational diabetes or other uncontrolled diabetes
  8. * Known to be immunocompromised

Contacts and Locations

Study Contact

Edward Michelson, MD
CONTACT
915 215 4600
edward.michelson@ttuhsc.edu

Principal Investigator

Susan Watts, PhD.
STUDY_DIRECTOR
Texas Tech University Health Sciences Center, Department of Emergency Medicine

Study Locations (Sites)

University Medical Center of El Paso
El Paso, Texas, 79905
United States

Collaborators and Investigators

Sponsor: Texas Tech University Health Sciences Center, El Paso

  • Susan Watts, PhD., STUDY_DIRECTOR, Texas Tech University Health Sciences Center, Department of Emergency Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-15
Study Completion Date2024-09-10

Study Record Updates

Study Start Date2023-09-15
Study Completion Date2024-09-10

Terms related to this study

Keywords Provided by Researchers

  • migraine headache
  • peripheral nerve block
  • dexamethasone
  • steroid treatment

Additional Relevant MeSH Terms

  • Migraine